AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
6.10
+0.06 (0.99%)
Sep 3, 2026, 12:29 PM EDT - Market open
AdaptHealth Revenue
AdaptHealth had revenue of $740.31M in the quarter ending June 30, 2026, with 12.66% growth. This brings the company's revenue in the last twelve months to $3.23B, up 4.17% year-over-year. In the year 2025, AdaptHealth had annual revenue of $3.24B, down -0.49%.
Revenue (ttm)
$3.23B
Revenue Growth
+4.17%
P/S Ratio
0.24
Revenue / Employee
$308,568
Employees
10,900
Market Cap
813.80M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.24B | -16.12M | -0.49% |
| Dec 31, 2024 | 3.26B | 60.80M | 1.90% |
| Dec 31, 2023 | 3.20B | 229.58M | 7.73% |
| Dec 31, 2022 | 2.97B | 516.06M | 21.02% |
| Dec 31, 2021 | 2.45B | 1.40B | 132.35% |
| Dec 31, 2020 | 1.06B | 526.75M | 99.45% |
| Dec 31, 2019 | 529.64M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | 192.56M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.67B |
| Varex Imaging | 865.00M |
| InMode | 374.63M |
| OrthoPediatrics | 252.72M |
| SI-BONE | 213.60M |
| Cytek Biosciences | 206.71M |
| Beta Bionics | 119.01M |
| CeriBell | 101.96M |
AHCO News
- 17 days ago - ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health - PRNewsWire
- 19 days ago - AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information - GlobeNewsWire
- 23 days ago - AdaptHealth Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 25 days ago - AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law - Business Wire
- 26 days ago - AdaptHealth Corp. to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - AdaptHealth price target lowered to $10 from $14 at UBS - TheFly
- 4 weeks ago - AdaptHealth price target lowered to $8 from $15 at RBC Capital - TheFly
- 4 weeks ago - AdaptHealth price target lowered to $9 from $14 at Truist - TheFly